American Healthcare Reit vs Ventas
Ventas is the larger business, with $5.83bn of revenue in fiscal 2025 against $2.26bn for American Healthcare Reit (2.6 times as much). Ventas grew faster (18.5% against 9.1%). Ventas kept more of each dollar of sales as profit: a net margin of 4.3% against 3.1%. American Healthcare Reit carries less debt relative to equity (29.7% against 104.6%).
| Latest fiscal year | American Healthcare ReitAHR, 2025 | VentasVTR, 2025 |
|---|---|---|
| Revenue | $2.26bn | $5.83bn |
| Revenue growth | 9.1% | 18.5% |
| Net income | $69.8m | $251m |
| Operating margin | 18.4% | — |
| Net margin | 3.1% | 4.3% |
| Return on equity | 2.5% | 2.2% |
| Free cash flow | $294m | −$1.28bn |
| Cash | $115m | $741m |
| Total debt | $986m | $13.10bn |
| Debt to equity | 29.7% | 104.6% |
| Dividend per share | $1.00 | $1.92 |
| Dividend yield | 1.7% | 2.1% |
| Share buybacks | $0 | — |
| Employees | 121 | 542 |
| Market value | $10.68bn | $45.93bn |
| Price vs our value range | — | — |
| Moat score | 27 (Weak) | 26 (Weak) |
| Insider trades, 12 months | 0 buys, 10 sales | 1 buys, 20 sales |